This inventor holds 11 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 5 EPO patents. Top assignees: Eli Lilly and Company, Abbott Laboratories Corporation. Active years: 2000-2021.
Company Filing History:
Years Active: 2000-2021
Title: Discovering the Innovations of Jeffrey Michael Schkeryantz
Introduction:
Jeffrey Michael Schkeryantz, a prolific inventor based in Fishers, IN (US), has made significant contributions in the field of pharmaceuticals with a total of 11 patents to his name.
Latest Patents:
Among his latest patents is the groundbreaking invention of condensed thiophene derivatives as NaPi-IIb inhibitors. These compounds have shown promise in treating hyperphosphatemia, chronic kidney disease, and the associated cardiovascular conditions. Additionally, Schkeryantz has developed a TARP γ8 dependant AMPA receptor antagonist, opening new possibilities in neuropharmacology.
Career Highlights:
Schkeryantz has an impressive professional background, having worked at renowned companies such as Eli Lilly and Company and Abbott Laboratories Corporation. His expertise in drug discovery and development has been instrumental in advancing medical research and improving patient care.
Collaborations:
Throughout his career, Schkeryantz has collaborated with esteemed colleagues including James Allen Knobelsdorf and Albert Khilevich. Together, they have synergized their talents to drive innovation and push the boundaries of scientific discovery.
Conclusion:
In conclusion, Jeffrey Michael Schkeryantz stands as a beacon of ingenuity in the realm of pharmaceutical inventions. His dedication to advancing healthcare solutions through patented innovations underscores his commitment to making a lasting impact in the industry.